Tuberculosis and Risk of Emphysema among US Adults in the NHANES I Epidemiologic Follow-Up Study Cohort, 1971–1992

Tuberculosis and Risk of Emphysema among US Adults in the NHANES I Epidemiologic Follow-Up Study Cohort, 1971–1992

(1) Background: History of TB is a known risk factor for long-term respiratory impairment affecting lung functions in both restrictive and obstructive lung disease. (2) Methods: We analyzed data from the NHANES I Epidemiologic Follow-up Study (NHEFS), a longitudinal study conducted on a noninstituti...

Full description

Bibliographic Details
Main Authors:	Anita Joshi, L. Joseph Su, Mohammed S. Orloff
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Epidemiologia
Subjects:	Tuberculosis (TB) emphysema latent tuberculosis infection (LTBI) NHANES
Online Access:	https://www.mdpi.com/2673-3986/4/4/44

Similar Items

The association of blood metals with latent tuberculosis infection among adults and adolescents
by: Jinyi Wu, et al.
Published: (2023-11-01)

Tuberculosis infection among children under six in contact with smear positive cases: A study in a hyper endemic area of Iran
by: Mahdi Afshari, et al.
Published: (2023-02-01)

In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection
by: Peng Cheng, et al.
Published: (2022-06-01)

Tuberculosis Infection among Non–US-Born Persons and Persons ≥60 Years of Age, United States, 2019–2020
by: Rachel Woodruff, et al.
Published: (2023-07-01)

Designing, Development, and Evaluation of an Informatics Platform for Enhancing Treatment Adherence in Latent Tuberculosis Infection Patients: A Study Protocol
by: Rohitashwa Kumar, et al.
Published: (2023-03-01)

Prevalence of latent tuberculosis infection and incidence of active tuberculosis in school close contacts in Shanghai, China: Baseline and follow-up results of a prospective cohort study
by: Xiao Xiao, et al.
Published: (2022-09-01)

Diagnosis for Latent Tuberculosis Infection: New Alternatives
by: Claudia Carranza, et al.
Published: (2020-09-01)

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
by: Akanksha Verma, et al.
Published: (2022-12-01)

Feasibility of novel approaches to detect viable Mycobacterium tuberculosis within the spectrum of the tuberculosis disease
by: Sogol Alebouyeh, et al.
Published: (2022-08-01)

RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium tuberculosis Infection
by: Lingna Lv, et al.
Published: (2017-06-01)

Finding and treating both tuberculosis disease and latent infection during population-wide active case finding for tuberculosis elimination
by: Mikaela Coleman, et al.
Published: (2023-10-01)

Bovine Tuberculosis Case Intervention Using the T.SPOT.TB Assay to Screen Dairy Workers in Bailey County, Texas
by: Anabel Rodriguez, et al.
Published: (2020-09-01)

From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning
by: Lin-Sheng Li, et al.
Published: (2023-11-01)

Smoking Exposure and the Risk of Latent Tuberculosis Infection: Results from NHANES 2011–2012
by: Xinsong Hu, et al.
Published: (2024-01-01)

Editorial: Factors for the progression from latent tuberculosis infection to tuberculosis disease
by: Cheng Chen, et al.
Published: (2023-06-01)

Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?
by: Rosella Centis, et al.
Published: (2017-03-01)

Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis
by: Muki Shehu Shey, et al.
Published: (2023-05-01)

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays
by: Robert J. Blount, et al.
Published: (2016-08-01)

Targeting Non-Replicating <i>Mycobacterium tuberculosis</i> and Latent Infection: Alternatives and Perspectives (Mini-Review)
by: Anna Egorova, et al.
Published: (2021-12-01)

Investigation of Latent Tuberculosis with LIOFeron®TB/LTBI Test in Hemodialysis Patients
by: Hamide KAYA, et al.
Published: (2022-09-01)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
by: Matthew K. O'Shea, et al.
Published: (2018-12-01)

Prevalence of latent tuberculosis infection in the household contacts of pulmonary tuberculosis, time to treat
by: Vinnie Sarah Ch Sangma, et al.
Published: (2023-05-01)

Comparison of interferon gamma release assay and tuberculin skin test for diagnosis of latent tuberculosis in psoriasis patients planned for systemic therapy
by: Shekhar Neema, et al.
Published: (2022-01-01)

Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection
by: Misaki Wayengera, et al.
Published: (2018-03-01)

Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans
by: Ineke Spruijt, et al.
Published: (2020-03-01)

Systemic Inflammation in Pregnant Women With Latent Tuberculosis Infection
by: Shilpa Naik, et al.
Published: (2021-01-01)

Monocyte-to-Lymphocyte Ratio (MLR) as a Possible Prognostic Marker of Latent Tuberculosis (LTBI) among Household Contacts of Active Tuberculosis (TB) Patients
by: Rukhshan Khurshid, et al.
Published: (2022-02-01)

Prevalence and factors associated with tuberculosis infection in India
by: Sriram Selvaraju, et al.
Published: (2023-12-01)

Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies
by: Shweta Sharma, et al.
Published: (2023-03-01)

Consumption of Vitamin K and Vitamin A Are Associated With Reduced Risk of Developing Emphysema: NHANES 2007–2016
by: Tianjiao Shen, et al.
Published: (2020-04-01)

Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome
by: Xuezhi Wang, et al.
Published: (2022-11-01)

IP-10 for the Diagnosis and Treatment Monitoring of Tuberculosis in Children
by: Agnieszka Strzelak, et al.
Published: (2024-01-01)

Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
by: Wang CY, et al.
Published: (2019-07-01)

Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report
by: Li TL, et al.
Published: (2021-04-01)

Fragmentation of Healthcare Services as a Possible Determinant of the Low Completion for the Tuberculosis Cascade of Prevention among Asylum Seekers: Results from a Prospective Study with Historical Comparison
by: Valentina Marchese, et al.
Published: (2022-05-01)

Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19
by: Wenping Gong, et al.
Published: (2023-05-01)

Contacts of retreatment tuberculosis cases with a prior poor treatment outcome are at increased risk of latent tuberculosis infection
by: Davit Baliashvili, et al.
Published: (2016-02-01)

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection
by: Charles M. Bark, et al.
Published: (2017-07-01)

Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States
by: Yue Wang, et al.
Published: (2022-03-01)

Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data
by: Erica L. Stockbridge, et al.
Published: (2018-05-01)